Abera is a Swedish biotech company headquartered in Stockholm, Sweden. Abera is committed to becoming a world-leading company in innovative vaccine technologies.

MANAGEMENT TEAM

Anders Ericson

CEO, Chairman of the Board

Anders Ericson has worked in several positions within the financial industry for more than 18 years. He is the owner and CEO of Smallcap.se, which is a financial communications firm specializing in life science companies.

Joen Luirink

CSO, Member of the Board

Prof. Luirink has more than 35 years of experience in Biochemistry and Molecular Microbiology and authored over 140 original scientific publications in peer-reviewed journals. Prof. Luirink specializes in protein trafficking in bacteria. He is currently head of the Department of Molecular Microbiology at VU University Amsterdam, and serves as the CSO of Abera.

BOARD OF DIRECTORS

Anders Ericson

CEO, Chairman of the Board

Anders Ericson has worked in several positions within the financial industry for more than 18 years. He is the owner and CEO of Smallcap.se, which is a financial communications firm specializing in life science companies.

Joen Luirink

CSO, Member of the Board

Prof. Luirink has more than 35 years of experience in Biochemistry and Molecular Microbiology and authored over 140 original scientific publications in peer-reviewed journals. Prof. Luirink specializes in protein trafficking in bacteria. He is currently head of the Department of Molecular Microbiology at VU University Amsterdam, and serves as the CSO of Abera.

Alf Lindberg

Member of the Board

Prof. Alf Lindberg has held the CSO position and Director of R&D position at Wyeth Vaccines and Sanofi Pasteur. He has extensive experience in vaccine development and is also a former professor in Clinical Bacteriology at Karolinska Institute in Stockholm. Prof. Lindberg is active as board member in several biotech and vaccine development companies worldwide.